Invention Grant
- Patent Title: Tr1 cells for use in atherosclerosis
- Patent Title (中): Tr1细胞用于动脉粥样硬化
-
Application No.: US11660113Application Date: 2004-08-11
-
Publication No.: US07985409B2Publication Date: 2011-07-26
- Inventor: Hervé Groux , Alain Tedgui , Ziad Mallat , Valérie Brun
- Applicant: Hervé Groux , Alain Tedgui , Ziad Mallat , Valérie Brun
- Applicant Address: FR Paris FR Valbonne
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),TxCell
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale),TxCell
- Current Assignee Address: FR Paris FR Valbonne
- Agency: Young & Thompson
- International Application: PCT/IB2004/002858 WO 20040811
- International Announcement: WO2006/018674 WO 20060223
- Main IPC: A61K35/16
- IPC: A61K35/16
Abstract:
The present invention relates to a method of treating or preventing atherosclerosis comprising administering to a mammal in need of such a treatment a) an antigen which has been used to activate in vitro a Tri cell population originating from said mammal, and b) the TO cell population activated by said antigen, said TO cell population being obtained from a CD4+ T lymphocyte population of said mammal.
Public/Granted literature
- US20080107663A1 Tri1 Cells for Use in Atherosclerosis Public/Granted day:2008-05-08
Information query
IPC分类:
